Absorption of orally administered amphotericin B lozenges.
Open Access
- 26 July 1983
- journal article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 16 (1) , 106-108
- https://doi.org/10.1111/j.1365-2125.1983.tb02152.x
Abstract
The systemic absorption of amphotericin B, administered as a 10 mg lozenge, was investigated in 14 patients with malignancies, who received three or four doses daily during chronic administration. The mean plasma amphotericin B concentration, measured 3 h after the morning dose on from 1-20 occasions over a 1-80 day period, ranged among subjects from 46 +/- 13 ng/ml (s.d., n = 20) to 136 +/- 25 ng/ml (n = 19). Using the previously reported intravenous clearance of the drug, the fraction of the dose absorbed was estimated at 8.3-9.9%. This is considerably greater than that estimated from earlier reports (0.2- 0.9%), which used much higher oral doses (2-10 g/day).Keywords
This publication has 7 references indexed in Scilit:
- Elimination of amphotericin B in impaired renal functionClinical Pharmacology & Therapeutics, 1983
- Amphotericin B Pharmacokinetics in HumansAntimicrobial Agents and Chemotherapy, 1978
- Oral Administration of Solubilized Amphotericin BNew England Journal of Medicine, 1961
- Some aspects of the absorption, distribution, and excretion of amphotericin B in man.1958
- Coccidioidomycosis and its treatment with amphotericin BThe American Journal of Medicine, 1958
- An Evaluation of Amphotericin B In Vitro and In Vivo in Mice Against Coccidioides Immitis and Candida Albicans, and Preliminary Observations Concerning the Administration of Amphotericin B to Man*Journal of Investigative Dermatology, 1957